Dieter Haemmerich, Ph.D., CEO of OncoBLAZE (IMAGE)
Caption
Dr. Dieter Haemmerich was working on a way to deliver chemotherapy directly to cancer cells, but he needed a way to see in real time the path the chemotherapy was taking. From that need, SphynxVision was born. Photos by Clif Rhodes
Credit
MUSC Hollings Cancer Center
Usage Restrictions
Use with credit to MUSC.
License
Original content